LEXINGTON, Ky. (Oct. 1, 2021) – When staff and providers at Kentucky Children’s Hospital were charged with the task of setting up the primary site for pediatric monoclonal antibody therapy in Kentucky, they transformed an empty clinic space into a state-of-the-art infusion clinic. And they did it in just nine days.
“This whole space was a former clinic space that was being used for office space and storage,” said Matthew Horn, director of ambulatory clinical operations for Kentucky Children’s Hospital. “Everyone, from clinic staff to maintenance staff stepped up and transformed it into a place where we can administer life-saving treatment to children.”
The Specialty Infusion Clinic will serve as the primary state site for pediatric COVID monoclonal antibody infusions. Located in UK HealthCare’s Kentucky Clinic, staff can administer monoclonal antibody therapy to up to 26 patients a day.
Monoclonal antibodies, which have emergency authorized usage from the FDA, are similar to the antibodies your immune system would produce in response to an infection. They are mass produced and designed to target the coronavirus. The therapy is used to bolster the body’s own immune system to fight the virus but is not meant to be a substitution for the COVID-19 vaccine.
“This treatment is authorized in patients who are 12 and older – children who are old enough to be vaccinated,” said Sean McTigue, MD, interim chief of pediatric infectious diseases at KCH. “The infusion can prevent serious illness and hospitalization, but the vaccine is still the first and best line of defense.”
Patients ages 12 to 17 who test positive for COVID or have had a known exposure are eligible to receive infusions if they have high-risk factors such as:
- Obesity or being overweight (body mass index greater than 85 percent for their age and gender on CDC growth charts)
- Chronic kidney disease
- Immunosuppressive disease or immunosuppressive treatment
- Cardiovascular disease, including congenital heart disease
- Sickle cell disease
- Chronic lung disease including moderate to severe asthma, interstitial lung disease, cystic fibrosis and pulmonary hypertension
- Neurodevelopmental disorders such as cerebral palsy, genetic/metabolic syndromes, severe congenital anomalies
- Patients who are dependent on medical technology such as tracheostomy, gastrostomy, positive pressure ventilation not related to COVID-19
The Infusion Clinic has 13 infusion spaces with two rooms that can accommodate siblings. The infusion itself takes 30 minutes, but families can expect to spend about three hours at the clinic.
The Specialty Infusion Clinic is located at the Kentucky Clinic. Hours of operations are 3-9 p.m., Monday through Friday. This clinic, as well as the facility for adults, only accepts patients by referral. Please contact your primary care provider for a referral.
To get a COVID-19 vaccine, visit www.kycovid19.com to find vaccination site near you.
The University of Kentucky is increasingly the first choice for students, faculty and staff to pursue their passions and their professional goals. In the last two years, Forbes has named UK among the best employers for diversity, and INSIGHT into Diversity recognized us as a Diversity Champion four years running. UK is ranked among the top 30 campuses in the nation for LGBTQ* inclusion and safety. UK has been judged a “Great College to Work for" three years in a row, and UK is among only 22 universities in the country on Forbes' list of "America's Best Employers." We are ranked among the top 10 percent of public institutions for research expenditures — a tangible symbol of our breadth and depth as a university focused on discovery that changes lives and communities. And our patients know and appreciate the fact that UK HealthCare has been named the state’s top hospital for five straight years. Accolades and honors are great. But they are more important for what they represent: the idea that creating a community of belonging and commitment to excellence is how we honor our mission to be not simply the University of Kentucky, but the University for Kentucky.